Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 3181 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#3181, RRID:AB_331068
- Product name
- Phospho-CrkL (Tyr207) Antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse, Rat, Simian
- Host
- Rabbit
- Storage
- -20°C
Submitted references The proteolytic activity of separase in BCR-ABL-positive cells is increased by imatinib.
High- and low-affinity epidermal growth factor receptor-ligand interactions activate distinct signaling pathways.
Disruption of Bcr-Abl coiled coil oligomerization by design.
Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.
Haaß W, Stehle M, Nittka S, Giehl M, Schrotz-King P, Fabarius A, Hofmann WK, Seifarth W
PloS one 2012;7(8):e42863
PloS one 2012;7(8):e42863
High- and low-affinity epidermal growth factor receptor-ligand interactions activate distinct signaling pathways.
Krall JA, Beyer EM, MacBeath G
PloS one 2011 Jan 10;6(1):e15945
PloS one 2011 Jan 10;6(1):e15945
Disruption of Bcr-Abl coiled coil oligomerization by design.
Dixon AS, Pendley SS, Bruno BJ, Woessner DW, Shimpi AA, Cheatham TE 3rd, Lim CS
The Journal of biological chemistry 2011 Aug 5;286(31):27751-60
The Journal of biological chemistry 2011 Aug 5;286(31):27751-60
Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.
Roumiantsev S, Krause DS, Neumann CA, Dimitri CA, Asiedu F, Cross NC, Van Etten RA
Cancer cell 2004 Mar;5(3):287-98
Cancer cell 2004 Mar;5(3):287-98
No comments: Submit comment
No validations: Submit validation data